European Academy of Neurology/Movement Disorder Society‐European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies
Movement Disorders2022Vol. 37(7), pp. 1360–1374
Citations Over TimeTop 1% of 2022 papers
Günther Deuschl, Angelo Antonini, João Costa, Katarzyna Śmiłowska, Daniela Berg, Jean‐Christophe Corvol, Giovanni Fabbrini, Joaquim J. Ferreira, Thomas Foltynie, Pablo Mir, Anette Schrag, Klaus Seppi, Pille Taba, Evžen Růžička, Marianna Selikhova, Nicholas Henschke, Gemma Villanueva, Elena Moro
Abstract
Evidence for invasive therapies in PD is heterogeneous. Only some of these therapies have a strong scientific basis. They differ in their profile of effects and have been tested only for specific patient groups. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Related Papers
- → Update on Deep Brain Stimulation for Dyskinesia and Dystonia: A Literature Review(2016)18 cited
- → End of day dyskinesia in advanced Parkinson's disease can be eliminated by bilateral subthalamic nucleus or globus pallidus deep brain stimulation(2006)20 cited
- → OFF–off rebound dyskinesia in subthalamic nucleus deep brain stimulation of Parkinson's disease(2006)8 cited
- → Rescue pallidal stimulation for diphasic and stimulation‐induced dyskinesia after successful subthalamic stimulation for Parkinson's disease(2017)3 cited
- [Deep brain stimulation for movement disorders].(2019)